Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients

by Lenglet, Aurélie, Liabeuf, Sophie, Guffroy, Pauline, Fournier, Albert, Brazier, Michel, Massy, Ziad A.
Published 2013

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease

by Desjardins, Lucie, Liabeuf, Sophie, Lenglet, Aurélie, Lemke, Horst-Dieter, Vanholder, Raymond, Choukroun, Gabriel, Massy, Ziad A.
Published 2013

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?

by Liabeuf, Sophie, Glorieux, Griet, Lenglet, Aurelie, Diouf, Momar, Schepers, Eva, Desjardins, Lucie, Choukroun, Gabriel, Vanholder, Raymond, Massy, Ziad A.
Published 2013

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease

by Neirynck, Nathalie, Eloot, Sunny, Glorieux, Griet, Barreto, Daniela V., Barreto, Fellype C., Liabeuf, Sophie, Lenglet, Aurélie, Lemke, Horst D., Massy, Ziad A., Vanholder, Raymond
Published 2012

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients

by de Oliveira, Rodrigo Bueno, Liabeuf, Sophie, Okazaki, Hirokazu, Lenglet, Aurelie, Desjardins, Lucie, Lemke, Horst-Dieter, Vanholder, Raymond, Choukroun, Gabriel, Massy, Ziad A.
Published 2013

N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin

by Lenglet, Aurélie, Liabeuf, Sophie, Bodeau, Sandra, Louvet, Loïc, Mary, Aurélien, Boullier, Agnès, Lemaire-Hurtel, Anne Sophie, Jonet, Alexia, Sonnet, Pascal, Kamel, Said, Massy, Ziad A.
Published 2016